1319 related articles for article (PubMed ID: 18368611)
21. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
Soar K; Turner JJ; Parrott AC
J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
[TBL] [Abstract][Full Text] [Related]
22. Transition to and from injecting drug use among regular ecstasy users.
Dunn M; Degenhardt L; Bruno R
Addict Behav; 2010 Oct; 35(10):909-12. PubMed ID: 20587367
[TBL] [Abstract][Full Text] [Related]
23. The impact of comorbid cannabis and methamphetamine use on mental health among regular ecstasy users.
Scott LA; Roxburgh A; Bruno R; Matthews A; Burns L
Addict Behav; 2012 Sep; 37(9):1058-62. PubMed ID: 22607716
[TBL] [Abstract][Full Text] [Related]
24. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
Soar K; Parrott A; Turner J
J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
[TBL] [Abstract][Full Text] [Related]
25. The prevalence of psychotic symptoms among methamphetamine users.
McKetin R; McLaren J; Lubman DI; Hides L
Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
[TBL] [Abstract][Full Text] [Related]
26. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
McKetin R; Kelly E
Drug Alcohol Rev; 2007 Mar; 26(2):161-8. PubMed ID: 17364851
[TBL] [Abstract][Full Text] [Related]
27. Crime, drugs and distress: patterns of drug use and harm among criminally involved injecting drug users in Australia.
Kinner SA; George J; Campbell G; Degenhardt L
Aust N Z J Public Health; 2009 Jun; 33(3):223-7. PubMed ID: 19630840
[TBL] [Abstract][Full Text] [Related]
28. Driving under the influence among frequent ecstasy consumers in Australia: trends over time and the role of risk perceptions.
Matthews AJ; Bruno R; Dietze P; Butler K; Burns L
Drug Alcohol Depend; 2014 Nov; 144():218-24. PubMed ID: 25282306
[TBL] [Abstract][Full Text] [Related]
29. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia.
Degenhardt L; Black E; Breen C; Bruno R; Kinner S; Roxburgh A; Fry C; Jenkinson R; Ward J; Fetherston J; Weekley J; Fischer J
Drug Alcohol Rev; 2006 Sep; 25(5):403-12. PubMed ID: 16939934
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with driving under the influence of alcohol and drugs among an Australian sample of regular ecstasy users.
Matthews A; Bruno R; Johnston J; Black E; Degenhardt L; Dunn M
Drug Alcohol Depend; 2009 Feb; 100(1-2):24-31. PubMed ID: 19013726
[TBL] [Abstract][Full Text] [Related]
31. Emerging psychoactive substance use among regular ecstasy users in Australia.
Bruno R; Matthews AJ; Dunn M; Alati R; McIlwraith F; Hickey S; Burns L; Sindicich N
Drug Alcohol Depend; 2012 Jul; 124(1-2):19-25. PubMed ID: 22209387
[TBL] [Abstract][Full Text] [Related]
32. Comparative rates of violent crime among regular methamphetamine and opioid users: offending and victimization.
Darke S; Torok M; Kaye S; Ross J; McKetin R
Addiction; 2010 May; 105(5):916-9. PubMed ID: 20148788
[TBL] [Abstract][Full Text] [Related]
33. Contemporary cocaine use patterns and associated harms in Melbourne and Sydney, Australia.
Shearer J; Johnston J; Fry CL; Kaye S; Dillon P; Dietze P; Collins L
Drug Alcohol Rev; 2007 Sep; 26(5):537-43. PubMed ID: 17701517
[TBL] [Abstract][Full Text] [Related]
34. Extending drug ethno-epidemiology using agent-based modelling.
Moore D; Dray A; Green R; Hudson SL; Jenkinson R; Siokou C; Perez P; Bammer G; Maher L; Dietze P
Addiction; 2009 Dec; 104(12):1991-7. PubMed ID: 19804460
[TBL] [Abstract][Full Text] [Related]
35. Crystal methamphetamine: a source of added sexual risk for Hispanic men who have sex with men?
Fernández MI; Bowen GS; Warren JC; Ibañez GE; Hernandez N; Harper GW; Prado G
Drug Alcohol Depend; 2007 Jan; 86(2-3):245-52. PubMed ID: 16930858
[TBL] [Abstract][Full Text] [Related]
36. Risk and benefit perceptions of party drug use.
White B; Degenhardt L; Breen C; Bruno R; Newman J; Proudfoot P
Addict Behav; 2006 Jan; 31(1):137-42. PubMed ID: 15907371
[TBL] [Abstract][Full Text] [Related]
37. Crystalline methamphetamine use and methamphetamine-related harms in Australia.
Degenhardt L; Sara G; McKetin R; Roxburgh A; Dobbins T; Farrell M; Burns L; Hall WD
Drug Alcohol Rev; 2017 Mar; 36(2):160-170. PubMed ID: 27286742
[TBL] [Abstract][Full Text] [Related]
38. Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study.
Murphy PN; Wareing M; Fisk J
J Psychopharmacol; 2006 May; 20(3):447-55. PubMed ID: 16574719
[TBL] [Abstract][Full Text] [Related]
39. How do drug market changes affect characteristics of injecting initiation and subsequent patterns of drug use? Findings from a cohort of regular heroin and methamphetamine injectors in Melbourne, Australia.
Horyniak D; Stoové M; Degenhardt L; Aitken C; Kerr T; Dietze P
Int J Drug Policy; 2015 Jan; 26(1):43-50. PubMed ID: 25304048
[TBL] [Abstract][Full Text] [Related]
40. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.
Larance B; Degenhardt L; Copeland J; Dillon P
Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
